This invention regards the field of life science and food, fodder or medical supply industry. Especially main invention Lactobacillus ramunosasu (Lactobacillus rhamnosus) LC705 independence or Lactobacillus ramunosasu (Lactobacillus rhamnosus) GG and Lactobacillus ramunosasu (Lactobacillus rhamnosus) regards the constituent which includes purobaioteikusu which consists of LC705. In addition as for this invention it regards the constituent for using as a medicine. Furthermore this invention, Lactobacillus ramunosasu for producing the constituent in order to make the sustaining power increase for the virus which pulls up the breathing apparatus infection symptom remedy of the breathing apparatus infection symptom and/or in the constituent for preventing, and the target (Lactobacillus rhamnosus) LC705 independently use or Lactobacillus ramunosasu (Lactobacillus rhamnosus) regards the combined use with GG. In addition furthermore as for this invention, Lactobacillus ramunosasu for producing the constituent in order to make the sustaining power increase for the virus which pulls up the breathing apparatus infection symptom remedy of the breathing apparatus infection symptom in becoming an adult and/or in the constituent for preventing, and the adult target (Lactobacillus rhamnosus) the use of GG is stated. Furthermore this invention decreases the duplication of the influenza virus, delays, or is infected to the constituent, and the breathing apparatus infection symptom in order to inhibit, Lactobacillus ramunosasu for producing the constituent in order to augment anti- virus Characteristic site Cain or, in the target which has been infected, (Lactobacillus rhamnosus) it regards use. Furthermore manner in order it remedies or to prevent the breathing apparatus infection symptom, or, in the target, or in the adult target, this invention decreases the duplication of the influenza virus pulls up the breathing apparatus infection symptom manner in order to make the sustaining
